Dr. Arun Bhatt V-Konnect Clinical Trials in India New Rules

Veeda through its V-Konnect series interacted with Dr. Arun Bhatt and discussed about “Clinical Trials in India and its regulatory perspective with New CT rules”


be82f4be49d882da996a62ca57b38e12e57eec85.png

About the V- Konnect


V-Konnect interview series, is a program to get in touch with specialized industry experts to know their views on opinions on current relevant subject matters.

About Dr. Arun Bhatt - Consultant – Clinical Research & Development

Dr. Bhatt is currently working as a consultant in pharmaceutical medicine and clinical pharmacology. He is Editor-in-Chief of ISCR journal- Perspectives in Clinical Research. Dr. Bhatt has extensive three decades in the Indian pharmaceutical industry in clinical research, drug development and regulatory affairs. He was former President of ISCR, President at Clininvent, CEO of CMI (India experience of) and Medical Director at Novartis. He is been awarded with ISCR Special Award in 2017 for his contribution to Research Fraternity, Outstanding Service award by Drug Information Association in 2012, Honorary Fellowship by Clinical Research UK in 2009. He is also a qualified assessor of NABH Accreditation for Clinical Trials sites and have more than 150 publications in national and international journals.


Read at: https://lnkd.in/f8Grb9G